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The Samd9L Gene: Transcriptional Regulation and
Tissue-Specific Expression in Mouse Development
Qiujie Jiang1, Benjamin Quaynor1, Alex Sun1, Qiaoli Li1, Hirotaka Matsui2, Hiroaki Honda3, Toshiya Inaba2,
Eli Sprecher4 and Jouni Uitto1
Normophosphatemic familial tumoral calcinosis (NFTC) is caused by mutations in the SAMD9 gene. This gene is
absent in mouse, while there is a murine paralog, Samd9-like (Samd9L). To clarify the relationships between
SAMD9 and SAMD9L, we investigated the transcriptional regulation and expression pattern of mouse Samd9L.
AnB1.5-kb mouse Samd9L promoter fragment was cloned, and a series of 50 deletion constructs were linked to
a luciferase reporter gene. All constructs showed significant activity in transfected epithelial cells and mouse
fibroblasts, and the presence of regulatory cis-elements as close as 87 bp upstream of the transcription start site
was identified. Ras-responsive element binding protein 1 (Rreb-1) was identified in this region by protein–DNA
binding array. The expression of Samd9L was upregulated by calcitonin, and this was preceded by a significant
increase in the expression of Rreb-1 mRNA. Quantitative real-time PCR analysis of Samd9L revealed near-
ubiquitous expression, with the highest level in the kidney. Tissue-specific expression was also confirmed both
by in situ b-gal staining and quantitative enzymatic activity assay in a transgenic Samd9Lþ / mouse in which the
LacZ gene replaced exon 2 in the Samd9L gene. These findings assist in understanding the regulation of Samd9L
in the context of its paralogous gene, SAMD9, which harbors mutations in NFTC.
Journal of Investigative Dermatology (2011) 131, 1428–1434; doi:10.1038/jid.2011.61; published online 17 March 2011
INTRODUCTION
Familial tumoral calcinosis (MIM610455) is a group of
heritable disorders characterized by ectopic mineralization
of the extracellular matrix of connective tissues (Sprecher,
2010). The normophosphatemic variant, NFTC, manifests
with extensive mineralization of cutaneous tissues, associated
with inflammatory manifestations mostly evident in mucosal
tissues. Recently, mutations in NFTC have been demonstrated
in sterile alpha motif domain-containing 9 gene (SAMD9),
which encodes a cytoplasmic protein with currently un-
known function (Topaz et al., 2006; Chefetz et al., 2008). The
SAMD9 gene is located in the human chromosome 7q21
region, and next to it in head-to-tail orientation is a
paralogous gene, SAMD9-like (SAMD9L), both with similar
structures in that there is one large,B5–6 kb coding exon that
is preceded upstream by a large intron and either one
(SAMD9L) or several (SAMD9) relatively small non-coding
exons (Li et al., 2007). Both human genes encode a putative
protein of B170–190 kb with 58% sequence homology,
which in their amino-terminal segments display a well-
conserved sterile alpha motif domain potentially involved in
protein/protein interactions.
In a recent study, gene expression differences were noted
between cell cultures derived from an aggressive fibromatosis
tumor as compared with control tissue (Li et al., 2007).
In particular, reduced SAMD9 expression was noted in
aggressive fibromatosis, as well as in 20% of cases of
breast cancer and 35% of cases of colon cancer cell lines
compared with normal tissues. Thus, SAMD9 may have a role
in regulating cell proliferation and suppressing the neoplastic
phenotype. Recently, a common microdeletion cluster in the
7q21.3 subband region has been identified in patients with
myeloid leukemia and myelodysplastic syndrome (Asou
et al., 2009). This microdeletion region contains three genes,
SAMD9, SAMD9L, and Miki, which were postulated as
candidates for myeloid tumor suppressor genes on 7q.
Finally, SAMD9 has been suggested to be a key molecule
controlling cancer cell death in malignant glioma by Sendai
virus particle or interferon-b treatment (Tanaka et al., 2010).
With respect to ectopic mineralization, it was noted that the
NFTC patients generally develop calcium deposits in areas
subject to repeated trauma and associated with marked
inflammatory manifestations, suggesting that SAMD9 may
also have a role in the inflammatory response to tissue injury.
It has been speculated that TNF-a, a proinflammatory
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cytokine that links inflammation and apotosis, might have a
role in SAMD9 regulation (Sprecher, 2010). Besides these
observations, the physiological roles of SAMD9 and SAMD9L
are poorly understood.
An intriguing observation is that while an orthologous
gene of human SAMD9 exists in rat, the corresponding
gene is lost in mouse lineage owing to a unique genomic
rearrangement (Li et al., 2007). However, mice do have the
ortholog to human SAMD9L, but very little is known of the
regulation of the Samd9/Samd9L gene–gene system either in
human or in mouse. In this study, we have specifically
explored the spatial and temporal expression of the Samd9L
gene during mouse development, as well as in a novel mouse
‘‘knockout’’ model in which part of the Samd9L coding
region has been replaced by the LacZ gene.
RESULTS AND DISCUSSION
To gain insight into the tissue-specific expression of Samd9L,
a multiple mouse tissue panel was first screened for the
corresponding mRNA by quantitative real-time (RT)-PCR. The
results indicated high level of expression in kidney, followed
by spleen, stomach, and adrenal gland, when the level of
expression was normalized for mouse actin mRNA in the
same samples (Figure 1a). This near-ubiquitous expression
of mouse Samd9L is consistent with previous findings by
Li et al (2007) and Topaz et al (2006), who demonstrated that
SAMD9 and SAMD9L are expressed in all human adult, fetal,
and tumor tissues that were available from human multiple
tissue complementary DNA (cDNA) panels. During mouse
embryonic development at days 8.5 and 9.5, essentially no
expression was detected (Figure 1a, lanes 17 and 18), but
low levels were detectable at days 12.5 and 19 (Figure 1a,
lanes 19 and 20). RT-PCR of mouse kidney revealed low,
yet detectable levels of Samd9L mRNA at birth, and the
expression levels significantly increased during the subse-
quent 2 and 4 weeks of life (Figure 1b and c). Computerized
scanning analysis indicated that no further change in the
Samd9L mRNA levels in mouse kidney was noted between 4
and 40 weeks of life (Figure 1c).
To examine the transcriptional control of Samd9L gene
expression, an expression construct extending from 1,428
to þ98 was developed, and a number of 50-deletion
constructs were generated and linked to firefly luciferase
reporter (Figure 2a). Transfection of four cell lines, including
three epithelial cells and a mouse fibroblast cell line
(NIH3T3), in culture with these reporter plasmids showed
significant level of expression over controls mock transfected
with the basic vector (Figure 2b). The activity in epithelial
1 2 3
0
3
*
*
2.5
2
1.5
R
el
at
iv
e 
ex
pr
es
sio
n
1
0.5
0
0 2 4 40
Age (weeks)
Age (weeks)
2 4 40
4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Mouse Samd9L
Mouse actin
Mouse Samd9L
Mouse actin
Figure 1. Samd9L expression is tissue-specific and developmentally regulated. (a) Samd9L messenger RNA (mRNA) expression was assessed by PCR
using a pre-standardized complementary DNA library of multiple mouse tissues. The represented tissues are as follows: 1. Brain; 2. Heart; 3. Kidney; 4. Spleen;
5. Thymus; 6. Liver; 7. Stomach; 8. Small intestine; 9. Muscle; 10. Lung; 11. Testis; 12. Skin; 13. Adrenal gland; 14. Pancreas; 15. Uterus; 16. Prostate
gland; 17. Embryo/day 8.5; 18. Embryo/day 9.5; 19. Embryo/day 12.5; 20. Embryo/day 19. (b) The kidneys were harvested from the mice at the different ages.
Real-time (RT)-PCR analysis revealed that the expression of mouse Samd9L in the kidneys increased with age when mice at the age of 0 (newborn), 2, 4,
and 40 weeks were examined. (c) The levels of Samd9L mRNA expression were quantified by determining the pixel intensities of the bands of RT-PCR products
on the images in (b) using a computer program (ImageQuant, Molecular Dynamics, Sunnyvale, CA), and normalized with those of the corresponding
internal actin controls. Data from three independent measurements were used (mean±SD). The relative expression of mouse Samd9L was calculated
using the mRNA level of mouse Samd9L in the newborns as 1 (*Po0.05).
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cell cultures (TCMK-1, MLE-10, and human embryonic
kidney (HEK293) revealed that the shortest construct tested,
p-87-luciferase, showed the highest level of expression.
Inclusion of upstream sequences up to 1,428 resulted in
reduction of the activity, suggesting the presence of down-
regulatory elements. In all cultures, co-transfection of a
b-galactosidase expression plasmid (pRSV-b-gal) was included,
followed by b-galactosidase enzyme activity determination,
which was used to correct for transfection efficiencies. The
mouse fibroblast cell line (NIH3T3) showed reduced activity
by about 50% with the p-87 construct as compared with
other constructs tested containing the upstream sequences
(Figure 2b, lower right panel). It appears, therefore, that the
proximal promoter region within the segment 87 to þ98
contains the essential sequences necessary for high level of
expression particularly in epithelial cell cultures.
By searching for transcription factors that might regulate
the expression of the Samd9L promoter within the p-87
promoter fragment, nuclear extracts of NIH3T3 cells were
tested in a protein/DNA filter array containing 96 transcrip-
tion factors. A number of transcription factors were identified
to bind to the target sequence in p-87; however, search for
consensus sequences within the p-87 fragment identified the
corresponding cognate binding sites for only two of them,
E47 and Ras-responsive element binding protein (Rreb;
Figures 3a and b). E47 is widely expressed and binds
specifically to the immunoglobulin k-chain enhancer kE2. It
shows homology to other proteins with a Helix–Loop–Helix
dimerization domain signature of the MYC type. E47 has
been reported to be essential for normal B-cell hematopoiesis
(Frasca et al., 2003). RREB is a zinc-finger transcription factor
that binds to RAS-responsive elements of gene promoters
(Zhang et al., 2003). It has been shown that the calcitonin
gene promoter contains an RAS-responsive element and that
RREB-1 binds to it and increases expression of calcitonin
(Mukhopadhyay et al., 2007; Flajollet et al., 2009).
As RREB has been suggested to be responsive to
calcitonin, we tested the possibility that Samd9L gene
expression might be mediated by calcitonin through Rreb,
one of the transcription factors shown to bind to the proximal
87 promoter sequence. Incubation of NIH3T3 cells with
calcitonin showed over threefold increase in Samd9L gene
expression, which was statistically significant at 4 and 7 days
of incubation (Figure 4a). Parallel assay of Rreb mRNA levels
by RT-PCR revealed a statistical increase as early as at the
24-h point (Figure 4b).
To demonstrate the specificity of Rreb binding to the
promoter activity, transient cell transfections were done with
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Figure 2. Serially truncated 50 deletion constructs of the mouse Samd9L promoter display significant activities in various cell lines. (a) Serial deletion
constructs of the mouse Samd9L 50-flanking region were inserted upstream of firefly luciferase gene (Luc) in the reporter plasmid pGL3-Basic. The numbers on
the left indicate the 50-position of the construct, starting from the transcription start site (þ1; arrow). (b) The Samd9L promoter constructs (0.75 mg) described in
(a) or the control pGL3-Basic vector were cotransfected with 0.25mg of pRSV-b-galactosidase reporter plasmid into the indicated cell types using FuGENE6
reagent (Roche). The cells were lysed 50 hours later and assayed for luciferase and b-galactosidase activities. Luciferase activity was divided by b-galactosidase
activity to correct for transfection efficiency. The data are presented as the mean±SD of three separate experiments, each performed in triplicate. HEK293,
human embryonic kidney epithelial cell line; MLE-10, mouse liver epithelial cell line; NIH3T3, mouse skin fibroblast cell line; TCMK-1, mouse kidney epithelial
cell line.
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the wild-type p-87 plasmid reporter construct together with
three mutant constructs in which segments of the consensus
binding site of Rreb (-63/-49) were mutated (Figure 5a). The
wild-type construct showed over fourfold level of expression
of the luciferase reporter gene as compared with the control
plasmid (Figure 5b). No change was noted with Mutant 1,
while Mutant 2 showed approximately threefold increase
over the wild-type activity. Mutant 3 essentially abolished the
promoter activity (Figure 5b). Interestingly, the Mutant 2 also
mutates the consensus binding site of SRY, a testis-determin-
ing factor, which has been reported to also have a role in
hormonal influence on calcification (Yamada et al., 2006).
Further studies, such as those investigating gender differences
in SAMD9L expression, are needed to understand the role of
androgens in these processes.
The tissue-specific expression of the Samd9L promoter
was also assessed in in vivo situations by examination of a
heterozygous transgenic mouse in which exon 2 of the gene
was replaced by LacZ gene (Samd9Lþ /), and therefore
the expression of b-galactosidase was under the Samd9L
upstream regulatory sequences within the promoter. It should
be noted that these Samd9Lþ / mice, as well as their
homozygous counterparts, develop acute myelogenous leu-
kemia at high frequency after they reach the age of 20
months. This mouse model has been preliminarily reported
(Matsui et al., 2009), and a detailed manuscript is in
preparation (Matsui et al., unpublished). Dissection of differ-
ent tissues in Samd9Lþ / mice followed by b-galactosidase
staining confirmed the highest levels of expression in the
kidney and spleen, while the level of expession was very low
in the liver and the muscle (Figure 6a). Histochemical
staining of paraffin-embedded sections for b-galactosidase
revealed expression in both proximal and distal tubules
(Figure 6c). The localization of Samd9L protein in mouse
kidney was further confirmed by immunohistochemical
staining of paraffin sections of wild-type mouse kidney with
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Figure 3. Protein/DNA array identifies select transcription factors binding to the mouse Samd9L promoter region. (a) Hybridization signals of the transcription
factors bound to the p-87 promoter fragment identified in nuclear extracts of NIH3T3 cells. The TranSignal protein/DNA filter contains 96 transcription factors,
each tested in duplicate (adjacent horizontal dots). (b) The transcription factors identified by the protein/DNA array as binding to Samd9L promoter region are
indicated on shaded background. The selected transcription factors whose putative recognition sites were identified by TFSEARCH (version 1.3, Kyoto
University, Japan) in the p-87 promoter fragment are outlined by black frame in (a) and (b). Insufficient signal was noted for those factors shown on the white
background. (c) The sequence extending from 87 to þ 98 was scanned for transcription factor-binding sites by using TFSEARCH. The putative recognition
sites for select transcription factors identified in DNA are indicated below the sequence. The transcription initiation site is referred to by þ 1.
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a Samd9L primary antibody, which revealed expression in
tubules, but not in the glomeruli (Figure 6d).
The expression of b-galactosidase was also quantitatively
measured by enzymatic activity assay in the extracts from the
same tissues that were stained for b-gal in situ (Figure 6b).
Highest level of enzymatic activity, as determined spectro-
photometrically at 570 nm, after deduction of the background
reflecting endogenous b-galactosidase activity, showed that
the highest levels were observed in the kidney and the
spleen, confirming the results obtained by RT-PCR at the level
of mRNA expression, as shown in Figure 1a, and by
b-galactosidase staining in situ (Figure 6a).
In summary, the present study of mouse Samd9L revealed
near-ubiquitous expression, with the highest level in the
kidney, a major organ regulating calcium-phosphate home-
ostasis and the site of calcitonin hormonal action. The
transcriptional regulation of Samd9L as explored in this study
adds to our understanding of the potential role of this gene in
carcinogenesis. This information, in the context of the
regulation of the SAMD9 gene expression, may contribute
to our understanding of mineralization processes, such as
those taking place in NFTC.
MATERIALS AND METHODS
Animals
The Samd9L ‘‘knockout’’ mouse model was developed by homo-
logous recombination resulting in replacement of exon 2 in the
Samd9L gene by the LacZ gene (Matsui et al., 2009). C57/BL6 mice
were obtained from Jackson Labs (Bar Harbor, ME). All animal
studies were performed in accordance with the institutional guide-
lines of Thomas Jefferson University Animal Care and Use
Committee and the National Institutes of Health. Mice were placed
in cages in a temperature-controlled room with a 12-hour light–dark
cycle and free access to food and water.
Cell culture
All cell lines (NIH3T3, mouse skin fibroblasts; HEK293, human
embryonic kidney epithelial cells; MLE-10, mouse liver epithelial
cells; and TCMK-1, mouse kidney epithelial cells) were cultured in
Dulbecco’s modified Eagle’s medium and supplemented with 10%
heat-inactivated fetal bovine serum, 2mM; L-glutamine, 100 IUml1
penicillin, and 100 mgml1 streptomycin (Cellgro, Mediatech,
Herndon, VA). Cultures were maintained at 371C in a humidified
atmosphere of 5% CO2 and 95% air.
Antibodies
Antibodies to mouse Samd9L were raised in rabbits to the peptide
WPENKELDEDSTLIEC (Abgent, San Diego, CA). 40-6-Diamidino-2-
phenylindole was purchased from Invitrogen (Eugene, OR).
Immunofluorescence
Whole-mouse kidney was embedded in paraffin and cut into 8-mm
sections onto slides. The slides were then deparaffinized, permea-
bilized, and stained with anti-mouse Samd9L antibody at 1:500
dilution followed by Texas Red secondary (red) antibody at 1:300
dilution and counterstained with 40-6-diamidino-2-phenylindole
(blue) at 1:5000 dilution, or only stained with Texas Red secondary
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Figure 4. Calcitonin enhances the expression of mouse Samd9L and Rreb
genes in NIH3T3 cells in vitro. Real-time (RT)-PCR was performed using total
RNA isolated from NIH3T3 cells cultured with 200 ng/l calcitonin for the
indicated time periods using primers specific for Samd9L, Rreb, and Gapdh,
as described in Materials and Methods. The data were normalized to the
Gapdh endogenous control and are presented as fold change relative to
untreated cells (0 time point). Samd9L expression is presented in the top panel
(a) and Rreb expression in the bottom panel (b). Asterisks indicate statistical
significance (Po0.05) when compared with the corresponding controls.
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antibody at 1:300 dilution and counterstained with 40-6-diamidino-
2-phenylindole to serve as a control.
Promoter plasmid constructs
The serially truncated Samd9L promoter fragments, with their
50-ends ranging from 1428 to 87 and their 30-end being fixed at
þ 98, were prepared by PCR amplification of mouse genomic DNA
using sense primers containing a MluI restriction site, and all of
the constructs shared the same antisense primer containing an NheI
restriction site (Supplementary Table S1 online). The PCR products
were separated by gel electrophoresis and extracted from a gel slice
(Qiagen, Valencia, CA), then cloned into pCR-Blunt II-TOPO vector
using ZeroBlunt TOPO PCR Cloning kit (Invitrogen, Carlsbad, CA).
The plasmid was then digested with MluI and NheI and cloned into
pGL3-Basic luciferase vector (Promega, Madison, WI). Mutagenesis
of the Rreb-binding site in the p-87 reporter construct, spanning from
87 to þ 98, was performed by site-directed mutagenesis using the
QuikChange XL Site-Directed Mutagenesis kit (Stratagene, La Jolla,
CA) and the manufacturer’s instructions with specific primers. The
final constructs were sequenced in both directions to ensure correct
nucleotide sequence. Computer analysis of the promoter region of
Samd9L was conducted to detect putative cis-acting elements using
a transcription factor database (TFSEARCH, Kyoto University,
version 1.3).
Transient transfections and luciferase assay
Plasmid constructs used for transient transfection were prepared
using a purification kit (Qiagen). All cell lines (NIH3T3, HEK293,
MLE-10, TCMK-1) were plated on a 24-well plate 24 hours prior to
transfection and grown to approximately 80% confluency. The cells
in each well were cotransfected with 0.75 mg of experimental
plasmid and 0.25 mg of pRSV-b-galactosidase expression plasmid as
an internal control for transfection efficiency, using FuGENE6
transfection reagent according to the manufacturer’s instructions
(Roche Diagnostic, Indianapolis, IN). After incubation for 50 hours,
the transfected cells were harvested and assayed as previously
described. Each experiment was performed in triplicate.
Quantitative expression of mRNA in mouse tissues
RapidScan gene expression cDNA arrays containing mouse tissues for
quantitative PCR were purchased from OriGene (Rockville, MD). These
arrays contained prestandardized amounts of cDNA from 20 indepen-
dent mouse tissues. The cDNA was amplified by PCR using primers
specific for Samd9L (sense, located in exon 1: 50-CCTGGTGTCTC
TCAGCCAGT-30; antisense, located in exon 2: 50-CTTCATTCTGCCCT
GTCTCC-30). PCR products were separated by gel electrophoresis on a
2% agarose gel and stained with ethidium bromide.
RNA extraction and reverse transcription-PCR
NIH3T3 cells were plated on 100-mm dishes 24 hours prior to
treatment and allowed to grow to 60% confluence. The cells were
then washed with PBS and incubated with media containing 200 ng/l
calcitonin (American Peptide Company, Sunnyvale, CA) for the
indicated time period. Total RNA was extracted from NIH3T3 cells
using an RNeasy Mini Kit (Qiagen) following the manufacturer’s
instructions. Total RNA was treated with DNase I to eliminate
amplification of genomic DNA. The amount and quality of RNA
were verified by measuring the absorbance at 260/280 nm. Random-
primed reverse transcription of RNA was performed with the
Superscript First-Strand Synthesis System for RT-PCR (Invitrogen).
SYBR Green PCR amplification was performed in a model 7000
sequence detector (Applied Biosystems, Foster City, CA). The
reactions were carried out in a 96-well plate in a 25 ml reaction
volume containing 12.5ml of 2 SYBR Green PCR Master Mix
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(a) Various organs were harvested from Samd9Lþ / mice, in which the LacZ
gene replaced exon 2 in the Samd9L gene in one allele, and were analyzed by
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as the baseline, and the data were expressed after normalization to the
corresponding baselines and to the protein content of each extract. The
highest b-gal enzymatic activity was observed in the kidney and spleen.
(c) Paraffin sections of the b-gal-stained kidney confirmed localization in both
proximal and distal tubules. (d) Paraffin sections of WT mouse kidney were
stained with Samd9L primary antibody and Texas Red secondary antibody
and counterstained with 40-6-diamidino-2-phenylindole (DAPI) (right panel),
or stained only with Texas Red secondary antibody and DAPI (left panel).
The Samd9L was expressed in the tubules (arrows) but not in the glomeruli
(in rectangles). Scale bar, 100 mm.
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(Applied Biosystems), 0.3 nM concentrations of forward and reverse
primers each, and 10 ng of cDNA. Initial incubation at 951C for
15min was followed by 40 cycles of 95 1C for 15 seconds and either
56 1C (for Samd9L) or 60 1C (for Rreb) for 1minute. NIH3T3 cDNA
samples in triplicate were used in each run. The amount of specific
mRNA in each RNA sample was quantified and normalized to
Gapdh mRNA. The relative expression level of the target genes was
calculated using the DDCt method (Real-time PCR software; model
7000 sequence detector; Applied Biosystems). Reaction specificity
was determined by the dissociation curve immediately after the last
reaction cycle, and visualized with the software Dissociation Curve
1.0 (7000 sequence detection system; Applied Biosystems).
Protein/DNA array
A 187-bp fragment of the Samd9L promoter region, extending from
87 to þ 98, was excised from the p-87 construct with restriction
enzymes MluI and NheI, and labeled with biotin using Bio-16-dUTP
(Roche, Mannheim, Germany) and the Klenow fragment of
DNA polymerase I (Invitrogen). Unincorporated Bio-16-dUTP was
removed by a spin column and the biotin-labeled DNA fragment
was coupled to M-280 streptavidin magnetic beads (Dynal Biotech,
Oslo, Norway) using the manufacturer’s conditions. The DNA-
coupled magnetic beads were incubated with 500 mg protein from
NIH3T3 nuclear extract for 2 hours at 41C in the binding buffer as
previously described. After washing, the bound proteins were
dissociated from the DNA-coupled beads by incubating in a buffer
containing 2M NaCl for 60minutes on ice. The bound proteins
extracted from the 187-bp promoter region fragment were incubated
with the TranSignal (Panomics, Redwood, CA) probe mix, a set of 96
biotin-labeled DNA oligonucleotides corresponding to the consen-
sus sequences for the corresponding transcription factors, to allow
the formation of DNA/protein complexes. The transcription-factor
bound probes were isolated and then dissociated from the DNA/
protein complex and used to hybridize the TranSignal Array spotted
with complementary consensus-binding sequences of the transcrip-
tion factor probes according to the manufacturer’s instructions.
Hybridization signals were visible after exposure to X-ray film
following chemiluminescent detection.
b-Gal staining and quantitative enzymatic activity assay
To analyze the biodistribution and expression of the mouse Samd9L,
various tissues were isolated from adult Samd9Lþ / mice and examined
for beta-galactosidase expression in vivo. The tissues fixed with 4%
paraformaldehyde were stained for b-galactosidase using a LacZ
Detection kit (InvivoGen, San Diego, CA). The sections were lightly
counterstained with neutral red before mounting. For the enzyme activity
assays, the various tissues were harvested from either Samd9Lþ / mice
or wild-type mice, and tissue extracts were analyzed for beta-
galactosidase using a b-gal assay kit (Invitrogen) (Payet et al., 1998).
The beta-galactosidase activity in each tissue from wild-type mice was
used as the baseline. The data were expressed after normalization to the
corresponding baselines and to the protein content in each extract.
Statistical analysis
Statistical differences between the means in various groups were
calculated by Student’s two-tailed t-test.
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